Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
T. Inoue, Y. Yamamoto, K. Sato, Y. Nakamura, Y. Shimizu, M. Ogawa, T. Onodera, Y. Takahashi, T. Wakita, M. K. Kaneko, M. Fukasawa, Y. Kato, K. Noguchi
This study develops bispecific antibodies that restore effectiveness against SARS-CoV-2 variants resistant to existing antibodies by combining non-neutralizing antibodies targeting different epitopes.
bioRxiv · Oct 26, 2023Microbiology